A Simple Method for Quantifying Ultrasound-Triggered Microbubble Destruction

Ultrasound in Medicine and Biology

Volumn 37, Issue 6, 2011, Pages 949-957

  Hung, Shuo Hui ^a,b   Yeh, Chih Kuang ^c   Tsai, Tung Hu ^a   Chen, Tom ^b   Chen, Ran Chou ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Microbubble destruction; Pharmacokinetic; Time intensity curve; Ultrasound contrast agent

Indexed keywords

AREA UNDER THE CURVES; CLINICAL DIAGNOSTICS; CONCENTRATION-TIME; CONTRAST AGENT; DIAGNOSTIC ULTRASOUND; ENHANCEMENT DURATIONS; FEMORAL ARTERY; GOLD STANDARDS; HIND LIMBS; LINEAR PORTIONS; MECHANICAL INDICES; MICRO-BUBBLE; PEAK SIGNAL INTENSITIES; PHARMACOKINETIC ANALYSIS; REAL TIME MONITORING; SIGNAL INTENSITIES; SIGNAL SATURATION; SIMPLE METHOD; SONOGRAPHIC; SPRAGUE-DAWLEY RATS; TARGET SITES; TARGETED DRUG DELIVERY; TIME-INTENSITY CURVES; ULTRASOUND CONTRAST AGENT; ULTRASOUND SCANNERS;

CONCENTRATION (PROCESS); DRUG DELIVERY; PHARMACOKINETICS; RATS; SCANNING; SONICATION; ULTRASONICS; ULTRASONOGRAPHY;

ULTRASONIC APPLICATIONS;

SONOVUE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG HALF LIFE; FEMORAL ARTERY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MICROBUBBLE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ULTRASOUND; ULTRASOUND TRIGGERED MICROBUBBLE DESTRUCTION;

ANIMALS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MATERIALS TESTING; MICROBUBBLES; PHOSPHOLIPIDS; RADIATION DOSAGE; RATS; RATS, SPRAGUE-DAWLEY; SONICATION; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 79956114323     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.03.005     Document Type: Article

References (35)

1. Calderon C., Vilkomerson D., Mezrich R., Etzold K.F., Kingsley B., Haskin M. Differences in the attenuation of ultrasound by normal, benign, and malignant breast tissue. J Clin Ultrasound 1976, 4:249-254.
2. Chen W.S., Matula T.J., Brayman A.A., Crum L.A. A comparison of the fragmentation thresholds and inertial cavitation doses of different ultrasound contrast agents. J Acoust Soc Am 2003, 113:643-651.
3. Correas J.M., Bridal L., Lesavre A., Mejean A., Claudon M., Helenon O. Ultrasound contrast agents: Properties, principles of action, tolerance, and artifacts. Eur Radiol 2001, 11:1316-1328.
4. Deckers R., Rome C., Moonen C.T. The role of ultrasound and magnetic resonance in local drug delivery. J Magn Reson Imaging 2008, 27:400-409.
5. Forsberg F., Shi W.T., Merritt C.R., Dai Q., Solcova M., Goldberg B.B. On the usefulness of the mechanical index displayed on clinical ultrasound scanners for predicting contrast microbubble destruction. J Ultrasound Med 2005, 244:443-450.
6. Frenkel V., Etherington A., Greene M., Quijano J., Xie J., Hunter F., Dromi S., Li K.C. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: Investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad Radiol 2006, 13:469-479.
7. Goertz D.E., Wright C., Hynynen K. Contrast agent kinetics in the rabbit brain during exposure to therapeutic ultrasound. Ultrasound Med Biol 2010, 36:916-924.
8. Greenleaf W.J., Bolander M.E., Sarkar G., Goldring M.B., Greenleaf J.F. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998, 24:587-595.
9. Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1153-1166.
10. Huang S.L. Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1167-1176.
11. Korpanty G., Carbon J.G., Grayburn P.A., Fleming J.B., Brekken R.A. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 2007, 13:323-330.
12. Krix M., Plathow C., Kiessling F., Herth F., Karcher A., Essig M., Schmitteckert H., Kauczor H.U., Delorme S. Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. Ultrasound Med Biol 2004, 30:1355-1363.
13. Lampaskis M., Averkiou M. Investigation of the relationship of nonlinear backscattered ultrasound intensity with microbubble concentration at low MI. Ultrasound Med Biol 2010, 36:306-312.
14. Li J., Dong B., Yu X., Wang X., Li C. Grey-scale contrast enhancement in rabbit liver with SonoVue at different doses. Ultrasound Med Biol 2005, 31:185-190.
15. Lum A.F., Borden M.A., Dayton P.A., Kruse D.E., Simon S.I., Ferrara K.W. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release 2006, 111:128-134.
16. Miller D., Averkiou M., Brayman A., Everbach E., Holland C., Wible J., Wu J. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med 2008, 27:611-632.
17. Miller D.L., Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 2000, 26:661-667.
18. Morel D.R., Schwieger I., Hohn L., Terrettaz J., Llull J.B., Cornioley Y.A., Schneider M. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000, 35:80-85.
19. Phillips W.T., Goins B.A., Bao A. Radioactive liposomes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:69-83.
20. Porter T.M., Smith D.A., Holland C.K. Acoustic techniques for assessing the Optison destruction threshold. J Ultrasound Med 2006, 25:1519-1529.
21. Ricci P., Cantisani V., Ballesio L., Pagliara E., Sallusti E., Drudi F.M., Trippa F., Calascibetta F., Erturk S.M., Modesti M., Passariello R. Benign and malignant breast lesions: Efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med 2007, 28:57-62.
22. Schlosser T., Pohl C., Veltmann C., Lohmaier S., Goenechea J., Ehlgen A., Koster J., Bimmel D., Kuntz-Hehner S., Becher H., Tiemann K. Feasibility of the flash-replenishment concept in renal tissue: Which parameters affect the assessment of the contrast replenishment?. Ultrasound Med Biol 2001, 27:937-944.
23. Seidel G., Cangur H., Meyer-Wiethe K., Renault G., Herment A., Schindler A., Kier C. On the ability of ultrasound parametric perfusion imaging to predict the area of infarction in acute ischemic stroke. Ultraschall Med 2006, 27:543-548.
24. Sidhu P.S., Allan P.L., Cattin F., Cosgrove D.O., Davies A.H., Do D.D., Karakagil S., Langholz J., Legemate D.A., Martegani A., Llull J.B., Pezzoli C., Spinazzi A. Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: A multicentre study. Br J Radiol 2006, 79:44-51.
25. Skyba D.M., Price R.J., Linka A.Z., Skalak T.C., Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998, 98:290-293.
26. Smith D.A., Porter T.M., Martinez J., Huang S., MacDonald R.C., McPherson D.D., Holland C.K. Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med Biol 2007, 33:797-809.
27. Staples B.J., Roeder B.L., Husseini G.A., Badamjav O., Schaalje G.B., Pitt W.G. Role of frequency and mechanical index in ultrasonic-enhanced chemotherapy in rats. Cancer Chemother Pharmacol 2009, 64:593-600.
28. Tartis M.S., McCallan J., Lum A.F., LaBell R., Stieger S.M., Matsunaga T.O., Ferrara K.W. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol 2006, 32:1771-1780.
29. Tashjian J.A., Dewhirst M.W., Needham D., Viglianti B.L. Rationale for and measurement of liposomal drug delivery with hyperthermia using noninvasive imaging techniques. Int J Hyperthermia 2008, 24:79-90.
30. Tsai K.C., Liao Z.K., Yang S.J., Lin W.L., Shieh M.J., Hwang L.H., Chen W.S. Differences in gene expression between sonoporation in tumor and in muscle. J Gene Med 2009, 11:933-940.
31. Tsai T.H., Liu S.C., Tsai P.L., Ho L.K., Shum A.Y., Chen C.F. The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: A microdialysis study. Br J Pharmacol 2002, 137:1314-1320.
32. Ueda S., Yamaoka K., Yui J., Shigematsu A., Nakagawa T. Evaluation of capacity-limited first-pass effect through liver by three-points sampling in portal and hepatic veins and systemic artery. Pharm Res 2002, 19:852-857.
33. Walker K.W., Pantely G.A., Sahn D.J. Ultrasound-mediated destruction of contrast agents. Effect of ultrasound intensity, exposure, and frequency. Invest Radiol 1997, 32:728-734.
34. Yamaoka K., Nakagawa T., Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978, 6:165-175.
35. Yeh C.K., Su S.Y. Effects of acoustic insonation parameters on ultrasound contrast agent destruction. Ultrasound Med Biol 2008, 34:1281-1291.